These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 14667136)

  • 1. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
    Langdahl BL; Stenkjaer L; Carstens M; Tofteng CL; Eriksen EF
    Calcif Tissue Int; 2003 Sep; 73(3):237-43. PubMed ID: 14667136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Nov; 15(11):2222-30. PubMed ID: 11092403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women.
    Langdahl BL; Ralston SH; Grant SF; Eriksen EF
    J Bone Miner Res; 1998 Sep; 13(9):1384-9. PubMed ID: 9738510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy.
    Retornaz F; Paris F; Lumbroso S; Audran F; Tigoulet F; Michelon C; Jeandel C; Sultan C; Blain H
    Maturitas; 2006 Nov; 55(4):325-33. PubMed ID: 16759824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
    Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women.
    Yu MW; Yang YC; Yang SY; Chang HC; Liaw YF; Lin SM; Liu CJ; Lee SD; Lin CL; Chen PJ; Lin SC; Chen CJ
    Hepatology; 2002 Jul; 36(1):156-63. PubMed ID: 12085360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
    Rosa FE; dos Santos RM; Poli-Frederico RC; Canevari Rde A; Nishimoto IN; Magrin J; Rainho CA; Kowalski LP; Rogatto SR
    Arch Oral Biol; 2007 Aug; 52(8):732-9. PubMed ID: 17321486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
    Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
    González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
    Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
    Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
    Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.